Patients with cancer are at risk for potentially deadly toxicities from chemotherapy overtreatment if kidney function is not accurately estimated beforehand. New research suggested that the use of ...

The SELECT Trial has revealed the potential of semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, in combating kidney function decline among individuals with overweight or obesity and ...

Platinum-associated adverse events were more likely in patients with impaired kidney function assessed by serum creatinine and cystatin C -- warranting judicious adjustment of platinum chemotherapy ...

Supervised high-intensity interval training (HIIT) over 5 years reduced the risk for rapid decline in estimated glomerular filtration rate (eGFR) in community-dwelling adults aged 70-77 years.